Group structure
8 companies in 5 countries
Loading…
8 companies in 5 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 69
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABRAD FILM COATED TABLET 5 MG5 mg · Tablet, film coated | Ivabradine | Singapore | Authorised | 2024 |
| ABRAD FILM COATED TABLET 7.5 MG7.5 mg · Tablet, film coated | Ivabradine | Singapore | Authorised | 2024 |
| ADLARITY TRANSDERMAL SYSTEM 10 mg/24 hours10 mg/24 hours · Patch, extended release | Donepezil | Singapore | Authorised | 2025 |
| ADLARITY TRANSDERMAL SYSTEM 5 mg/24 hours5 mg/24 hours · Patch, extended release | Donepezil | Singapore | Authorised | 2025 |
| ALLUTAMIDE SOFT CAPSULES 40mg40 mg · Capsule, liquid filled | Enzalutamide | Singapore | Authorised | 2026 |
| ALSUNI CAPSULES 12.5MG12.5 mg · Capsule | Sunitinib | Singapore | Authorised | 2022 |
| ALSUNI CAPSULES 50MG50.0 mg · Capsule | Sunitinib | Singapore | Authorised | 2022 |
| ALVOSTAT FILM COATED TABLETS 20MG20mg · Tablet, film coated | Rosuvastatin | Singapore | Authorised | 2016 |
| ALVOTROL TABLETS 10 MG10.000 mg · Tablet | Ezetimiba | Singapore | Authorised | 2017 |
| ASTRODAL CAPSULES 100MG100mg · Capsule | Temozolomide | Singapore | Authorised | 2016 |
| ASTRODAL CAPSULES 20MG20.0mg · Capsule | Temozolomide | Singapore | Authorised | 2016 |
| Bosutinib Lotus 100 mg filmomhulde tablettenFilmomhulde tablet | Bosutinib | Netherlands | Authorised | 2025 |
| Bosutinib Lotus 400 mg filmomhulde tablettenFilmomhulde tablet | Bosutinib | Netherlands | Authorised | 2025 |
| Bosutinib Lotus 500 mg filmomhulde tablettenFilmomhulde tablet | Bosutinib | Netherlands | Authorised | 2025 |
| CONJUPRI TABLETS 2.5MG2.50 mg · Tablet | Levamlodipine | Singapore | Authorised | 2024 |
| CONJUPRI TABLETS 5MG5.00 mg · Tablet | Levamlodipine | Singapore | Authorised | 2024 |
| DESROXIA FILM-COATED TABLETS 360MG360.00 mg · Tablet, film coated | Deferasirox | Singapore | Authorised | 2025 |
| DESROXIA FILM-COATED TABLETS 90MG90.00 mg · Tablet, film coated | Deferasirox | Singapore | Authorised | 2025 |
| Dydrogesteron Lotus 10 mg filmomhulde tablettenFilmomhulde tablet | Dydrogesterone | Netherlands | Authorised | 2024 |
| EVISTA TABLET 60 mg60 mg · Tablet, film coated | Raloxifene | Singapore | Authorised | 1999 |
| GVEZA FILM COATED TABLETS 3MG/ 0.03MG3.00 mg + 0.03 mg · Tablet, film coated | Drospirenona, Ethinyl estradiol | Singapore | Authorised | 2016 |
| JASTINDA FILM COATED TABLETS 3MG/ 0.02MG3.00 mg + 0.02 mg · Tablet, film coated | Drospirenona, Ethinyl estradiol | Singapore | Authorised | 2016 |
| LEAXOLAR CAPSULES 110 mg110 mg · Capsule | Dabigatran etexilate | Singapore | Authorised | 2025 |
| LEAXOLAR CAPSULES 150 mg150 mg · Capsule | Dabigatran etexilate | Singapore | Authorised | 2025 |
| LEAXOLAR CAPSULES 75 mg75 mg · Capsule | Dabigatran etexilate | Singapore | Authorised | 2025 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 50 | 50 | 0 | CompaniesAll medicines |
| Netherlands | 13 | 13 | 0 | CompaniesAll medicines |
| Saudi Arabia | 5 | 5 | 0 | CompaniesAll medicines |
| United States | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Colombia, Malaysia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Report an error or request removalCorrections from the company itself are welcome.
Keep Lotus’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence